OverviewChartNewsTraderScreen

AETERNA ZENTARIS INC/  CA0079755017  /

Toronto
2024-04-18  6:03:41 PM Chg. -0.09 Volume Bid10:00:04 PM Ask10:00:04 PM High Low
2.67CAD -3.26% 179
Turnover: 267		 2.67Bid Size: 1,000 2.78Ask Size: 3,000 2.67 2.67
GlobeNewswire 03-28 Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
GlobeNewswire 03-28 Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
GlobeNewswire 03-27 Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completio...
GlobeNewswire 03-12 Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
GlobeNewswire 03-12 Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
GlobeNewswire 02-26 Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders V...
GlobeNewswire 02-26 Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders V...
GlobeNewswire 02-23 Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceu...
GlobeNewswire 02-15 Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Sec...
GlobeNewswire 02-15 Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meetin...
GlobeNewswire 2023-12-16 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RAIN, BLBX, AEZS
GlobeNewswire 2023-12-14 Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Comp...
GlobeNewswire 2023-11-09 Aeterna Zentaris Reports Third Quarter 2023 Financial Results
GlobeNewswire 2023-10-11 Aeterna Zentaris to Participate at the Virtual Investor Ask the CEO Conference
GlobeNewswire 2023-09-05 Aeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire 2022-03-29 Aeterna Zentaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business O...
GlobeNewswire 2022-03-21 Aeterna Zentaris Provides Update on Ongoing Pivotal Phase 3 DETECT-Trial for the Diagnosis of Childh...
GlobeNewswire 2022-03-10 Aeterna Zentaris Announces Expansion of Research Program with Julius-Maximilians-University Wuerzbur...
GlobeNewswire 2022-03-02 Aeterna Zentaris Announces Notice of Allowance for U.S. Patent Covering AEZS-150 for the Potential T...
GlobeNewswire 2022-02-07 Aeterna Zentaris to Present at the 2022 BIO CEO & Investor Conference
GlobeNewswire 2022-01-26 Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rul...
GlobeNewswire 2022-01-26 Aeterna Zentaris Provides Business Outlook and Outlines Pipeline Priorities
GlobeNewswire 2022-01-20 Aeterna Zentaris to Present at the Virtual Investor 2022 Top Picks Conference
GlobeNewswire 2022-01-05 Aeterna Zentaris to Present at the H.C. Wainwright BioConnect Conference
GlobeNewswire 2021-12-23 Aeterna Zentaris Appoints Giuliano La Fratta as Chief Financial Officer